Bisoprolol 5mg + Amlodipine 5mg Tablet in pharma franchise in Maharashtra

Bisoprolol 5mg + Amlodipine 5mg Tablet in PCD pharma franchise in Jaipur

Bisoprolol 5mg + Amlodipine 5mg Tablet in top pharma company in Lucknow

Bisoprolol 5mg + Amlodipine 5mg Tablet in PCD pharma supplier in Pune

Bisoprolol 5mg + Amlodipine 5mg Tablet in pharma franchise company in India
Bisoprolol 5mg + Amlodipine 5mg Tablet in pharma distributor in Nagpur

Home/Products /bisoprolol-5-mg-amlodipine-5-mg-tablet

Bisopair AM 5 Tablet

Composition : Bisoprolol 5mg + Amlodipine 5mg Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹88/-

Bisopair A5 Tablet is a combination of Bisoprolol (5 mg) and Amlodipine (5 mg), formulated to effectively manage high blood pressure (hypertension) and prevent cardiovascular complications. This combination works through two mechanisms: Bisoprolol, a beta-blocker, reduces the heart rate and cardiac workload, while Amlodipine, a calcium channel blocker, relaxes blood vessels to improve blood flow and lower blood pressure.

By reducing blood pressure and easing the heart’s workload, Bisopair A5 Tablet significantly decreases the risk of heart attacks, strokes, and other cardiovascular diseases. It is especially beneficial for patients who require dual therapy to control hypertension or those with co-existing conditions like angina (chest pain) or mild heart failure.

This medication is prescribed for long-term use and should be taken once daily at the same time, with or without food, as directed by a healthcare provider. Patients should avoid abrupt discontinuation, as it may lead to rebound hypertension or worsened heart conditions. Those with pre-existing heart rhythm disorders, asthma, severe kidney or liver diseases should use it cautiously and under strict medical supervision.

Read More

About the Product

Bisopair A5 Tablet is a combination of Bisoprolol (5 mg) and Amlodipine (5 mg), formulated to effectively manage high blood pressure (hypertension) and prevent cardiovascular complications. This combination works through two mechanisms: Bisoprolol, a beta-blocker, reduces the heart rate and cardiac workload, while Amlodipine, a calcium channel blocker, relaxes blood vessels to improve blood flow and lower blood pressure.

By reducing blood pressure and easing the heart’s workload, Bisopair A5 Tablet significantly decreases the risk of heart attacks, strokes, and other cardiovascular diseases. It is especially beneficial for patients who require dual therapy to control hypertension or those with co-existing conditions like angina (chest pain) or mild heart failure.

This medication is prescribed for long-term use and should be taken once daily at the same time, with or without food, as directed by a healthcare provider. Patients should avoid abrupt discontinuation, as it may lead to rebound hypertension or worsened heart conditions. Those with pre-existing heart rhythm disorders, asthma, severe kidney or liver diseases should use it cautiously and under strict medical supervision.

Common side effects may include dizziness, fatigue, headache, swelling in the legs (due to Amlodipine), slow heart rate, and nausea. In rare cases, it may cause low blood pressure, breathing difficulties, or severe allergic reactions.

Used for the treatment of hypertension (high blood pressure) and angina (chest pain), reducing cardiovascular risks.

To be used under medical supervision. Avoid sudden discontinuation without consulting a doctor. Patients with severe heart conditions or low blood pressure should use it cautiously.

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation